Dr. Franz et al., CLINICAL RECOGNITION AND MANAGEMENT OF PATIENTS EXPOSED TO BIOLOGICALWARFARE AGENTS, JAMA, the journal of the American Medical Association, 278(5), 1997, pp. 399-411
Concern regarding the use of biological agents-bacteria, viruses, or t
oxins-as tools of warfare or terrorism has led to measures to deter th
eir use or, failing that, to deal with the consequences. Unlike chemic
al agents, which typically lead to violent disease syndromes within mi
nutes at the site of exposure, diseases resulting from biological agen
ts have incubation periods of days. Therefore, rather than a paramedic
, it will likely be a physician who is first faced with evidence of th
e results of a biological attack. We provide here a primer on 10 class
ic biological warfare agents to increase the likelihood of their being
considered in a differential diagnosis. Although the resultant diseas
es are rarely seen in many countries today, accepted diagnostic and ep
idemiologic principles apply; if the cause is identified quickly, appr
opriate therapy can be initiated and the impact of a terrorist attack
greatly reduced.